A trial of Ampion(TM) in patients with nasal inflammation (rhinitis).

Trial Profile

A trial of Ampion(TM) in patients with nasal inflammation (rhinitis).

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Dec 2011

At a glance

  • Drugs DMI 9523 (Primary)
  • Indications Rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Dec 2011 New trial record
    • 10 Nov 2011 Results released in an Ampio Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top